Skip to content
Screener

Neumora Therapeutics, Inc. NMRA Q2 2026 earnings

Reported August 14, 2026 · Before market open

EPS-$0.23Beat by $0.01
EPS estimate-$0.24

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.19

FAQ

When did Neumora Therapeutics, Inc. report Q2 2026 earnings?
Neumora Therapeutics, Inc. (NMRA) reported Q2 2026 earnings on August 14, 2026 before market open.
What were Neumora Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Neumora Therapeutics, Inc. reported eps of $-0.23 for Q2 2026.
Did Neumora Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.24 by $0.01.
How did Neumora Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 30.3% from $-0.33.
Where can I find Neumora Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-350349) and the 10-Q periodic report (0001193125-26-350370) directly on SEC EDGAR. The filing index links above go to sec.gov.